143 related articles for article (PubMed ID: 31094746)
1. Dextromethorphan Analgesia in a Human Experimental Model of Hyperalgesia.
Martin E; Narjoz C; Decleves X; Labat L; Lambert C; Loriot MA; Ducheix G; Dualé C; Pereira B; Pickering G
Anesthesiology; 2019 Aug; 131(2):356-368. PubMed ID: 31094746
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers.
Frymoyer AR; Rowbotham MC; Petersen KL
J Pain; 2007 Jan; 8(1):19-25. PubMed ID: 17113353
[TBL] [Abstract][Full Text] [Related]
3. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans.
Ilkjaer S; Dirks J; Brennum J; Wernberg M; Dahl JB
Br J Anaesth; 1997 Nov; 79(5):600-5. PubMed ID: 9422898
[TBL] [Abstract][Full Text] [Related]
4. CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model.
Mathiesen O; Imbimbo BP; Hilsted KL; Fabbri L; Dahl JB
J Pain; 2006 Aug; 7(8):565-74. PubMed ID: 16885013
[TBL] [Abstract][Full Text] [Related]
5. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
6. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
Warncke T; Stubhaug A; Jørum E
Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.
Hughes AM; Rhodes J; Fisher G; Sellers M; Growcott JW
Br J Clin Pharmacol; 2002 Jun; 53(6):604-12. PubMed ID: 12047485
[TBL] [Abstract][Full Text] [Related]
8. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
Sang CN; Booher S; Gilron I; Parada S; Max MB
Anesthesiology; 2002 May; 96(5):1053-61. PubMed ID: 11981142
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of l-4-chlorokynurenine in healthy volunteers.
Wallace M; White A; Grako KA; Lane R; Cato AJ; Snodgrass HR
Scand J Pain; 2017 Oct; 17():243-251. PubMed ID: 29229209
[TBL] [Abstract][Full Text] [Related]
10. Effect of preoperative oral dextromethorphan on immediate and late postoperative pain and hyperalgesia after total abdominal hysterectomy.
Ilkjaer S; Bach LF; Nielsen PA; Wernberg M; Dahl JB
Pain; 2000 May; 86(1-2):19-24. PubMed ID: 10779656
[TBL] [Abstract][Full Text] [Related]
11. Intravenous dextromethorphan to human volunteers: relationship between pharmacokinetics and anti-hyperalgesic effect.
Duedahl TH; Dirks J; Petersen KB; Romsing J; Larsen NE; Dahl JB
Pain; 2005 Feb; 113(3):360-368. PubMed ID: 15661445
[TBL] [Abstract][Full Text] [Related]
12. The effect of the preemptive use of the NMDA receptor antagonist dextromethorphan on postoperative analgesic requirements.
Helmy SA; Bali A
Anesth Analg; 2001 Mar; 92(3):739-44. PubMed ID: 11226111
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of a randomized double-blind clinical trial in breast cancer: dextromethorphan in chemotherapy-induced peripheral neuropathy.
Martin E; Morel V; Joly D; Villatte C; Delage N; Dubray C; Pereira B; Pickering G
Contemp Clin Trials; 2015 Mar; 41():146-51. PubMed ID: 25636304
[TBL] [Abstract][Full Text] [Related]
14. Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery.
Wadhwa A; Clarke D; Goodchild CS; Young D
Anesth Analg; 2001 Feb; 92(2):448-54. PubMed ID: 11159249
[TBL] [Abstract][Full Text] [Related]
15. Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.
Morel V; Pickering G; Etienne M; Dupuis A; Privat AM; Chalus M; Eschalier A; Daulhac L
Fundam Clin Pharmacol; 2014 Dec; 28(6):671-80. PubMed ID: 24702319
[TBL] [Abstract][Full Text] [Related]
16. Viscerosomatic facilitation in a subset of IBS patients, an effect mediated by N-methyl-D-aspartate receptors.
Verne GN; Price DD; Callam CS; Zhang B; Peck J; Zhou Q
J Pain; 2012 Sep; 13(9):901-9. PubMed ID: 22958874
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan and pain after total abdominal hysterectomy.
McConaghy PM; McSorley P; McCaughey W; Campbell WI
Br J Anaesth; 1998 Nov; 81(5):731-6. PubMed ID: 10193285
[TBL] [Abstract][Full Text] [Related]
18. The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers.
Gustorff B; Hoechtl K; Sycha T; Felouzis E; Lehr S; Kress HG
Anesth Analg; 2004 Feb; 98(2):401-407. PubMed ID: 14742378
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia.
Weinbroum AA; Gorodezky A; Niv D; Ben-Abraham R; Rudick V; Szold A
Can J Anaesth; 2001 Feb; 48(2):167-74. PubMed ID: 11220426
[TBL] [Abstract][Full Text] [Related]
20. Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects.
Staud R; Vierck CJ; Robinson ME; Price DD
J Pain; 2005 May; 6(5):323-32. PubMed ID: 15890634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
